CMB 0.00% 0.9¢ cambium bio limited

Ann: Appendix 4E - Preliminary final report-unaudited, page-4

  1. 640 Posts.
    lightbulb Created with Sketch. 66
    I agree with you.

    Great t20, strong director holdings.

    Profiting from progenza.

    Successful phase 1 in knee osteopathic pain with Progenza. Planning phase 1 in other areas + phase 2.

    20m MC has to be one of the cheaper med techs on the asx with a low dilution.

    As with other med/bio techs, I reckon $rgs has probably been restricted by the rona pandemic.

    If they keep in the green and manage $ properly without share dilution, I reckon this could boom very quickly.

    I reckon $rgs is due for a reversal. Fingers crossed.
 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
(20min delay)
Last
0.9¢
Change
0.000(0.00%)
Mkt cap ! $6.894M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
4 720236 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 559566 4
View Market Depth
Last trade - 16.12pm 29/04/2024 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.